Centre Testing International Group Co. Ltd.

SZSE:300012 Voorraadrapport

Marktkapitalisatie: CN¥22.7b

Centre Testing International Group Toekomstige groei

Future criteriumcontroles 1/6

Centre Testing International Group zal naar verwachting groeien in winst en omzet met respectievelijk 14.6% en 11.9% per jaar. De winst per aandeel zal naar verwachting groeien met 14.2% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 14.4% zijn.

Belangrijke informatie

14.6%

Groei van de winst

14.2%

Groei van de winst per aandeel

Professional Services winstgroei26.9%
Inkomstengroei11.9%
Toekomstig rendement op eigen vermogen14.4%
Dekking van analisten

Good

Laatst bijgewerkt18 Nov 2024

Recente toekomstige groei-updates

Centre Testing International Group Co. Ltd. Just Missed EPS By 25%: Here's What Analysts Think Will Happen Next

Apr 21
Centre Testing International Group Co. Ltd. Just Missed EPS By 25%: Here's What Analysts Think Will Happen Next

Recent updates

We Think Centre Testing International Group (SZSE:300012) Can Stay On Top Of Its Debt

Nov 21
We Think Centre Testing International Group (SZSE:300012) Can Stay On Top Of Its Debt

Centre Testing International Group Co. Ltd.'s (SZSE:300012) Price Is Right But Growth Is Lacking After Shares Rocket 33%

Oct 13
Centre Testing International Group Co. Ltd.'s (SZSE:300012) Price Is Right But Growth Is Lacking After Shares Rocket 33%

The Returns At Centre Testing International Group (SZSE:300012) Aren't Growing

Sep 24
The Returns At Centre Testing International Group (SZSE:300012) Aren't Growing

Little Excitement Around Centre Testing International Group Co. Ltd.'s (SZSE:300012) Earnings

Aug 28
Little Excitement Around Centre Testing International Group Co. Ltd.'s (SZSE:300012) Earnings

A Look At The Fair Value Of Centre Testing International Group Co. Ltd. (SZSE:300012)

Aug 05
A Look At The Fair Value Of Centre Testing International Group Co. Ltd. (SZSE:300012)

Investors Met With Slowing Returns on Capital At Centre Testing International Group (SZSE:300012)

Jun 04
Investors Met With Slowing Returns on Capital At Centre Testing International Group (SZSE:300012)

Centre Testing International Group's (SZSE:300012) Shareholders Will Receive A Bigger Dividend Than Last Year

May 22
Centre Testing International Group's (SZSE:300012) Shareholders Will Receive A Bigger Dividend Than Last Year

At CN¥12.48, Is It Time To Put Centre Testing International Group Co. Ltd. (SZSE:300012) On Your Watch List?

May 13
At CN¥12.48, Is It Time To Put Centre Testing International Group Co. Ltd. (SZSE:300012) On Your Watch List?

Earnings Troubles May Signal Larger Issues for Centre Testing International Group (SZSE:300012) Shareholders

Apr 25
Earnings Troubles May Signal Larger Issues for Centre Testing International Group (SZSE:300012) Shareholders

Centre Testing International Group Co. Ltd. Just Missed EPS By 25%: Here's What Analysts Think Will Happen Next

Apr 21
Centre Testing International Group Co. Ltd. Just Missed EPS By 25%: Here's What Analysts Think Will Happen Next

A Look At The Fair Value Of Centre Testing International Group Co. Ltd. (SZSE:300012)

Mar 28
A Look At The Fair Value Of Centre Testing International Group Co. Ltd. (SZSE:300012)

Is Centre Testing International Group (SZSE:300012) A Risky Investment?

Mar 14
Is Centre Testing International Group (SZSE:300012) A Risky Investment?

Returns On Capital Are Showing Encouraging Signs At Centre Testing International Group (SZSE:300012)

Feb 28
Returns On Capital Are Showing Encouraging Signs At Centre Testing International Group (SZSE:300012)

Winst- en omzetgroeiprognoses

SZSE:300012 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (CNY Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20267,7131,2666971,67913
12/31/20256,8411,1275771,50015
12/31/20246,1039635811,35315
9/30/20245,919916342991N/A
6/30/20245,838919361977N/A
3/31/20245,679898371977N/A
12/31/20235,6059104691,122N/A
9/30/20235,5979803641,054N/A
6/30/20235,5099704651,159N/A
3/31/20235,3409275051,174N/A
1/1/20235,1319034581,100N/A
9/30/20224,9338564541,080N/A
6/30/20224,6928063971,000N/A
3/31/20224,475766388997N/A
1/1/20224,3297465121,073N/A
9/30/20214,2307334461,000N/A
6/30/20214,0376873871,033N/A
3/31/20213,8736644521,066N/A
12/31/20203,568578385931N/A
9/30/20203,328514379888N/A
6/30/20203,191509355760N/A
3/31/20203,074444234665N/A
1/1/20203,183476349795N/A
9/30/20193,051469282699N/A
6/30/20192,923379384785N/A
3/31/20192,798340320708N/A
12/31/20182,681270239684N/A
9/30/20182,538195-80477N/A
6/30/20182,358145N/A293N/A
3/31/20182,191106N/A322N/A
12/31/20172,118134N/A349N/A
9/30/20171,998127N/A413N/A
6/30/20171,866125N/A431N/A
3/31/20171,768113N/A390N/A
12/31/20161,652102N/A363N/A
9/30/20161,506181N/A281N/A
6/30/20161,391158N/A250N/A
3/31/20161,312170N/A228N/A
12/31/20151,288181N/A277N/A
9/30/20151,155137N/A241N/A
6/30/20151,077135N/A235N/A
3/31/2015991138N/A240N/A
12/31/2014926146N/A252N/A
9/30/2014853132N/A232N/A
6/30/2014823143N/A203N/A
3/31/2014800142N/A223N/A
12/31/2013777150N/A238N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei 300012 ( 14.6% per jaar) ligt boven de spaarquote ( 2.8% ).

Winst versus markt: De winst van 300012 ( 14.6% per jaar) zal naar verwachting langzamer groeien dan de markt CN ( 26.2% per jaar).

Hoge groeiwinsten: De winst van 300012 zal naar verwachting groeien, maar niet aanzienlijk.

Omzet versus markt: De omzet van 300012 ( 11.9% per jaar) zal naar verwachting langzamer groeien dan de markt CN ( 13.8% per jaar).

Hoge groei-inkomsten: De omzet van 300012 ( 11.9% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen 300012 zal naar verwachting over 3 jaar laag zijn ( 14.4 %).


Ontdek groeibedrijven